Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,948.00    4.00 (0.08%)
Bid:
4,956.00
Ask:
4,964.00
Spread: 8.00 (0.161%)
Market Cap: £2.31b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Pre-close trading update

17 Dec 2009 07:00

RNS Number : 2597E
Morgan Sindall PLC
17 December 2009
 



17 Dec 2009

Morgan Sindall plc

Morgan Sindall plc, the construction and regeneration group, provides the following period end trading update in advance of the announcement of its preliminary results for the year ended 31 December 2009, expected to be in late February 2010. 

Trading

As previously announced in our Interim Management Statement on 10 November, Morgan Sindall remains on track to achieve its expectations for the current year, despite the challenging market conditions in which it is operating. 

Fit Out is performing strongly in tough market conditions with margins remaining robust and it continues to see a recovery in the level of tendering activity.

Construction is still experiencing healthy demand from the public sector and, in particular, is currently advancing two major projects at preferred bidder stage, Tayside Mental Health (£100m) and Hull BSF (£200m). We expect to achieve financial close on these projects during the first quarter of 2010. There remains considerable uncertainty over future public spending commitments.

Infrastructure Services continues to perform well in reasonably buoyant market conditions and the division continues to progress a number of major opportunities. Although the bidding processes are proving more protracted than initially anticipated, we continue to await the outcome of preferred bidder decisions on a number of contracts. 

Affordable Housing is still seeing a reasonable pipeline of refurbishment and new build social housing opportunities. This is complemented by improvements in demand for open market housing with sales continuing to improve.

Urban Regeneration's market remains subdued although we expect recovery in market conditions in the longer term.

The Investments division is seeing a strong pipeline of opportunities and we expect that it will increase its level of bidding activity in 2010, thereby taking advantage of the Group's increasing ability to deliver larger and more complex projects since the acquisition made in 2007.

Outlook

The Group's forward order book has reduced from £3.6bn to £3.2bn since 30 June 2009. However, this forward order book is supplemented by over £900m of projects at preferred bidder stage, all of which have been awarded during the second half of this year. 

We remain mindful of the challenges facing the sector in the longer term and continue to shape our business accordingly. Each of our divisions continues to particularly focus on cash management, cost reduction and supply chain improvements, as well as responding to market growth opportunities where they present themselves.

In summary, Morgan Sindall is on track to meet our expectations for 2009 and is well placed to meet the challenges and opportunities in 2010.

Enquiries:

Morgan Sindall plc

Tel: 020 7307 9200

Paul Smith, Chief Executive

David Mulligan, Finance Director

Blythe Weigh Communications

Tel: 020 7138 3204 

Tim Blythe

Mob: 07816 924626

Paul Weigh

Mob: 07989 129658 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTCKAKBOBDDNBD
Date   Source Headline
19th Aug 202211:00 amRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSHalf-year Report
1st Aug 202210:16 amRNSTotal Voting Rights
11th Jul 20227:00 amRNSNotice of Results
1st Jul 202210:50 amRNSTotal Voting Rights
14th Jun 202212:51 pmRNSAdditional Listing
6th Jun 202212:00 pmRNSTotal Voting Rights
1st Jun 20223:49 pmRNSDirector Declaration
17th May 20221:47 pmRNSHolding(s) in Company
10th May 202211:23 amRNSAdditional Listing
5th May 20224:45 pmRNSResult of AGM
5th May 20227:00 amRNSAGM Trading Update
3rd May 20223:48 pmRNSTotal Voting Rights
20th Apr 202210:25 amRNSBlock listing Interim Review
5th Apr 202210:40 amRNSAdditional Listing
5th Apr 20227:00 amRNSMeet the Management Forum
1st Apr 202210:36 amRNSTotal Voting Rights
24th Mar 202212:46 pmRNSAnnual Financial Report
18th Mar 202211:57 amRNSDirector/PDMR Shareholding
16th Mar 20223:03 pmRNSDirector/PDMR Shareholding
16th Mar 20229:23 amRNSDirector/PDMR Shareholding
16th Mar 20229:21 amRNSDirector/PDMR Shareholding
8th Mar 20224:00 pmRNSAdditional Listing
8th Mar 20228:27 amRNSHolding(s) in Company
7th Mar 20221:55 pmRNSDirector/PDMR Shareholding
7th Mar 20221:51 pmRNSDirector/PDMR Shareholding
4th Mar 20224:04 pmRNSDirector/PDMR Shareholding
4th Mar 20224:00 pmRNSDirector/PDMR Shareholding
1st Mar 20222:39 pmRNSTotal Voting Rights
24th Feb 20227:00 amRNSFinal Results
7th Feb 20227:00 amRNSNotice of Results
1st Feb 202211:41 amRNSTotal Voting Rights
4th Jan 20223:15 pmRNSTotal Voting Rights
21st Dec 202111:42 amRNSDirector Declaration
7th Dec 20212:26 pmRNSAdditional Listing
30th Nov 20214:53 pmRNSTotal Voting Rights
9th Nov 202112:51 pmRNSAdditional Listing
3rd Nov 20217:00 amRNSTrading Update
1st Nov 20219:24 amRNSTotal Voting Rights
20th Oct 202110:57 amRNSBlock listing Interim Review
20th Oct 20218:43 amRNSChange in Directors' Details
7th Oct 20218:44 amRNSAdditional Listing
4th Oct 20213:27 pmRNSHolding(s) in Company
1st Oct 20219:50 amRNSTotal Voting Rights
24th Sep 20218:00 amRNSHolding(s) in Company
22nd Sep 20218:19 amRNSHolding(s) in Company
7th Sep 20211:19 pmRNSAdditional Listing
2nd Sep 20217:26 amRNSHolding(s) in Company
1st Sep 202111:44 amRNSTotal Voting Rights
10th Aug 20213:13 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.